The Canadian Embassy in Korea announced that it will participate in ‘BIO KOREA 5 (Bio Korea 10)’, which will be held at COEX in Seoul for three days from Wednesday, May 12th to Friday, May 3th.
The Commercial Affairs Department of the Canadian Embassy in Korea, part of the Canadian Federal Government’s Ministry of Foreign Affairs and Trade, provides Canadian companies with Korean market information, verified Korean company information, business cooperation opportunities, and advice on entering overseas markets. It also plays a role in supporting the creation of new business opportunities and strengthening cooperation between the two countries, such as providing Korean companies with opportunities to cooperate with Canadian companies, information on related events, and support for investment and entry into Canada.
In particular, this year is a meaningful year in which Korea and Canada celebrate the 60th anniversary of diplomatic relations, and it is expected that Canadian companies will be able to interact more actively with Korean companies through this exhibition.
An embassy official said, “Canada, the world’s 9th largest pharmaceutical and bio market, has over 1,000 bio companies operating, the second largest number in the world. In particular, AI-based pharmaceutical and bio companies are active, and they also have strengths in fields such as precision medicine, anticancer and antibody medicines, and cell therapy.”
He continued, “The Commercial Affairs Department of the Canadian Embassy in Korea organizes a Canadian trade mission every year to support the creation of cooperation opportunities and networking between Korean and Canadian companies. Through this, the number of cases of various Canadian companies entering into successful partnerships with Korean companies is increasing, and in addition to licensing in/out, joint R&D cooperation is taking place,” he said. “We will continue to help innovative Canadian companies advance into Korea.” “We will promote active cooperation between the two countries by supporting Korean companies that wish to cooperate with Canadian companies,” he said.
Canadian companies participating in BIO KOREA 2023 12 companies
▲’Atuka’, a company specializing in testing neurodegenerative diseases targeting primates ▲’Biohubx’, a Canadian non-profit organization based in Alberta that supports bio companies in the growth and scale-up stage ▲’BOLD’, an innovative new drug that is an anti-resistant ruthenium-based small molecule tumor treatment -100′ development company ‘Bold Therapeutics’ ▲’Centre for Infectious Disease Genomics and One Health (CIDGOH), which studies the impact of infectious diseases on human and animal health by combining various knowledge engineering techniques, bioinformatics tools, and molecular research experiments. ), Simon Fraser University’ ▲’Cyclica’, a data-based new drug development company that investigates the multiple pharmacological properties of small molecules ▲’Discovery DNA’, a genetic testing company that helps users accurately understand their health information ▲Immune-oncology drugs, gene therapy, vaccines ‘Genvira Biosciences’, a virus vector engineering drug development company for development ▲ ‘Immugenia’, an early-stage immunotherapy specialist developing a new CAR therapy that engineers hematopoietic stem cells to treat and prevent recurrence of cancer ▲ Developing next-generation antibody treatments ‘iProgen Biotech’, a bio company specializing in the preclinical stage, ▲ ‘My Next Health (MNH)’, a company specializing in genomics and AI machine learning ▲ Life science institutions are improving IT and quality processes by reducing costs, improving productivity, and strengthening compliance (compliance) ‘Novatek International’ helps leverage investments in ▲’Qidni Labs’ develops a portable, water-free, battery-powered dialysis system for kidney failure patients
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, is hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.